Related Experiment Video
Updated: Jun 2, 2026
09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Best clinical trials reported in 2010.
John B Garner1, Paul A Grayburn, Clyde W Yancy
1Baylor University Medical Center/Jack and Jane Hamilton Heart Hospital, Baylor Heart and Vascular Institute, Dallas, Texas, USA.
The American Journal of Cardiology
|May 3, 2011
Summary
This review highlights key clinical trials from 2010 with the potential to change cardiovascular medicine practice. It provides summaries and analyses to help clinicians identify impactful research findings.
Area of Science:
- Cardiovascular Medicine
- Clinical Trials Research
Background:
- Clinicians face challenges in identifying clinical trial results that significantly alter medical practice.
- Distinguishing practice-changing findings from incremental benefits requires careful evaluation of emerging research.
Purpose of the Study:
- To review selected clinical trials published in 2010 with the potential to change clinical practice in cardiovascular medicine.
- To provide clinicians with a resource to identify impactful research findings from the past year.
Main Methods:
- Systematic review of clinical trials reported in 2010.
- Analysis of studies presented in journals, society meetings, and conferences.
- Categorization of findings by subject area for clarity.
Main Results:
- Identification of key clinical trials with significant implications for cardiovascular medicine.
- Detailed summaries and comprehensive tables of trial hypotheses, interventions, methods, endpoints, results, and implications.
- A curated bibliography for further in-depth reading.
Conclusions:
- The compilation serves as a valuable tool for clinicians to integrate evidence-based advancements into daily practice.
- Understanding the impact of recent clinical trials is crucial for advancing cardiovascular care.
- This review aims to facilitate informed decision-making for better patient outcomes.
More Related Videos
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...